News und Analysen
EQS-News: Carl Zeiss Meditec schließt das Geschäftsjahr 2023/24 mit leicht rückläufigem Umsatz ab – Prognose für bereinigtes EBIT erreicht
EQS-News: Carl Zeiss Meditec schließt das Geschäftsjahr 2023/24 mit leicht rückläufigem Umsatz ab – Prognose für bereinigtes EBIT erreicht
EQS-News: Gerresheimer AG: Change in the Supervisory Board
EQS-News: Gerresheimer AG: Change in the Supervisory Board
EQS-News: Gerresheimer: Science Based Targets Initiative confirms CO2e Reduction Targets
EQS-News: Gerresheimer: Science Based Targets Initiative confirms CO2e Reduction Targets
EQS-News: Gerresheimer: Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen
EQS-News: Gerresheimer: Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen
EQS-Adhoc: Gerresheimer AG: Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen
EQS-Adhoc: Gerresheimer AG: Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen
EQS-Adhoc: Gerresheimer AG: Initial findings of an external independent investigation into revenue recognition from bill-and-hold agreements in the 2024 financial year
EQS-Adhoc: Gerresheimer AG: Initial findings of an external independent investigation into revenue recognition from bill-and-hold agreements in the 2024 financial year
EQS-News: Gerresheimer: FDA grants Approval of SQ Innovation’s Lasix® ONYU*
EQS-News: Gerresheimer: FDA grants Approval of SQ Innovation’s Lasix® ONYU*
EQS-News: Gerresheimer: Business performance and slower market growth require guidance adjustment
EQS-News: Gerresheimer: Business performance and slower market growth require guidance adjustment
EQS-Adhoc: Gerresheimer AG: Business performance and slower market growth require adjustment of guidance for 2025
EQS-Adhoc: Gerresheimer AG: Business performance and slower market growth require adjustment of guidance for 2025
EQS-News: Gerresheimer Expands Wertheim Site with new Production Facility for Ready-to-fill Vials
EQS-News: Gerresheimer Expands Wertheim Site with new Production Facility for Ready-to-fill Vials
EQS-News: Gerresheimer comments on the audit by German BaFin
EQS-News: Gerresheimer comments on the audit by German BaFin
EQS-News: Gerresheimer AG: Wolf Lehmann to take over CFO position at Gerresheimer on September 1, 2025
EQS-News: Gerresheimer AG: Wolf Lehmann to take over CFO position at Gerresheimer on September 1, 2025
EQS-News: Gerresheimer expands financial flexibility to implement growth strategy
EQS-News: Gerresheimer expands financial flexibility to implement growth strategy
EQS-News: Gerresheimer AG: Achim Schalk To Join the Gerresheimer Management Board
EQS-News: Gerresheimer AG: Achim Schalk To Join the Gerresheimer Management Board
EQS-News: Carl Zeiss Meditec grows revenue and earnings in the first nine months of 2024/25
EQS-News: Carl Zeiss Meditec grows revenue and earnings in the first nine months of 2024/25
EQS-News: Gerresheimer to Separate Moulded Glass and Intends to Initiate a Subsequent Sales Process
EQS-News: Gerresheimer to Separate Moulded Glass and Intends to Initiate a Subsequent Sales Process
EQS-Adhoc: Gerresheimer AG to Separate Moulded Glass and Intends to Initiate a Subsequent Sales Process
EQS-Adhoc: Gerresheimer AG to Separate Moulded Glass and Intends to Initiate a Subsequent Sales Process
EQS-News: Gerresheimer ends discussions with private equity investors about a potential takeover offer
EQS-News: Gerresheimer ends discussions with private equity investors about a potential takeover offer
EQS-Adhoc: Gerresheimer AG: Discussions on potential takeover offer ended
EQS-Adhoc: Gerresheimer AG: Discussions on potential takeover offer ended
EQS-News: Gerresheimer Achieves A- Score in CDP Rating
EQS-News: Gerresheimer Achieves A- Score in CDP Rating
EQS-News: Gerresheimer in H1 2025: Bormioli Pharma boosts revenues and earnings, continued market influences in operating business
EQS-News: Gerresheimer in H1 2025: Bormioli Pharma boosts revenues and earnings, continued market influences in operating business
EQS-Adhoc: Gerresheimer AG reacts to media reports
EQS-Adhoc: Gerresheimer AG reacts to media reports
EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care AG resolves share buyback program with a total volume of EUR 1 billion in tranches within 2 years
EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care AG resolves share buyback program with a total volume of EUR 1 billion in tranches within 2 years
EQS-News: Gerresheimer AG: Annual General Meeting approves key proposed resolutions by a large majority
EQS-News: Gerresheimer AG: Annual General Meeting approves key proposed resolutions by a large majority
EQS-News: Gerresheimer Adjusts Guidance for Financial Year 2025
EQS-News: Gerresheimer Adjusts Guidance for Financial Year 2025